This is the authors' abstract. We don't add key points for this paper.
Immunoglobulin D (IgD) myeloma is an uncommon subtype of multiple myeloma and accounts for less than 2% of all myeloma patients. Plasmablastic myeloma is a rare morphological variant of multiple myeloma with a poor prognosis, and its association with IgD paraprotein is extremely rare. We report a patient who had the diagnosis of IgD myeloma with plasmablastic morphology and presented with multiple FDG-PET avid bone lesions, mimicking metastatic malignancy.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Mohamed et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: